{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:37:24Z","timestamp":1794544644652,"version":"4.9.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biomaterials.2025.123205","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:17:31Z","timestamp":1740395851000},"page":"123205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Platelet-derived extracellular vesicle drug delivery system loaded with kaempferol for treating corneal neovascularization"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-724X","authenticated-orcid":false,"given":"Guei-Sheung","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-147X","authenticated-orcid":false,"given":"Huai-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Widhibrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erh-Hsuan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Delila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-4030","authenticated-orcid":false,"given":"Ching-Li","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123205_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib2","first-page":"15","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management, Rom","volume":"63","author":"Sharif","year":"2019","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2025.123205_bib3","first-page":"28","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis. (London, England)"},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123205_bib4","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/molecules25153468","article-title":"Pharmacological potential of small molecules for treating corneal neovascularization","volume":"25","author":"Barry","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123205_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ajo.2005.05.020","article-title":"Deep corneal neovascularization after implantation with intrastromal corneal ring segments","volume":"140","author":"Al-Torbak","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123205_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123205_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080365","article-title":"Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration","volume":"11","author":"Garc\u00eda-Quintanilla","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123205_bib8","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123205_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.06.071","article-title":"Nanoparticle-mediated corneal neovascularization treatments: toward new generation of drug delivery systems","volume":"34","author":"Zhu","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123205_bib10","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/ijms19092830","article-title":"Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application","volume":"19","author":"Tsai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123205_bib11","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2025.123205_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1026386","article-title":"Platelets and platelet extracellular vesicles in drug delivery therapy: a review of the current status and future prospects","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123205_bib13","first-page":"496","article-title":"Targeting capabilities of native and bioengineered extracellular vesicles for drug delivery","volume":"9","author":"Frolova","year":"2022","journal-title":"Bioengineering (Basel, Switzerland)"},{"key":"10.1016\/j.biomaterials.2025.123205_bib14","article-title":"Advances in biological function and clinical application of small extracellular vesicle membrane proteins","volume":"11","author":"Huang","year":"2021","journal-title":"Front. oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123205_bib15","first-page":"344","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design, Extracell. Vesicles Circ","volume":"5","author":"Hagedorn","year":"2024","journal-title":"Nucleic Acids"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123205_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tibtech.2020.10.004","article-title":"Prospective therapeutic applications of platelet extracellular vesicles","volume":"39","author":"Johnson","year":"2021","journal-title":"Trends Biotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123205_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOH.0b013e32833e77ee","article-title":"Clinical relevance of microparticles from platelets and megakaryocytes","volume":"17","author":"Italiano","year":"2010","journal-title":"Curr. Opin. Hematol."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123205_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13123","article-title":"Platelet-rich plasma-derived extracellular vesicles: a superior alternative in regenerative medicine?","volume":"54","author":"Wu","year":"2021","journal-title":"Cell Prolif."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123205_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/09537104.2022.2105829","article-title":"In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration","volume":"33","author":"Widyaningrum","year":"2022","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-023-00972-w","article-title":"Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery","volume":"30","author":"Burnouf","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"15","key":"10.1016\/j.biomaterials.2025.123205_bib21","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1242\/jcs.00610","article-title":"Regulation of keratinocyte shape, migration and wound epithelialization by IGF-1- and EGF-dependent signalling pathways","volume":"116","author":"Haase","year":"2003","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.16803","article-title":"Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model","volume":"7","author":"Guo","year":"2017","journal-title":"Theranostics"},{"issue":"28","key":"10.1016\/j.biomaterials.2025.123205_bib23","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1080\/10408398.2022.2067121","article-title":"Kaempferol: a flavonoid with wider biological activities and its applications","volume":"63","author":"Bangar","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib24","first-page":"29","article-title":"Antiangiogenic role of natural flavonoids and their molecular mechanism: an update, Egypt","volume":"33","author":"Subbaraj","year":"2021","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123205_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/01635580802666281","article-title":"Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells","volume":"61","author":"Luo","year":"2009","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123205_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115862","article-title":"The potential benefits of polyphenols for corneal diseases","volume":"169","author":"Feng","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2237134","article-title":"Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization","volume":"34","author":"Wu","year":"2023","journal-title":"Platelets"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123205_bib29","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.3390\/ijms25073703","article-title":"Specific binding of alzheimer's a\u03b2 peptides to extracellular vesicles","volume":"25","author":"Coughlan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123205_bib30","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.3390\/ijms22168580","article-title":"Platelet-derived extracellular vesicles for regenerative medicine","volume":"22","author":"Antich-Rossell\u00f3","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123205_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7150\/thno.65098","article-title":"Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123205_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/pharmaceutics11120635","article-title":"Development of kaempferol-loaded gelatin nanoparticles for the treatment of corneal neovascularization in mice","volume":"11","author":"Chuang","year":"2019","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123205_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1042\/CS20150103","article-title":"NADPH oxidase 2 plays a role in experimental corneal neovascularization","volume":"130","author":"Chan","year":"2016","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123205_bib34","first-page":"612","article-title":"In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis","volume":"40","author":"Becker","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123205_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245143","article-title":"Effects of TNF\u03b1 receptor TNF-Rp55- or TNF-Rp75- deficiency on corneal neovascularization and lymphangiogenesis in the mouse","volume":"16","author":"Maier","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123205_bib36","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","article-title":"Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab","volume":"32","author":"Chu","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.biomaterials.2025.123205_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.791954","article-title":"Inhibition of neovascularization and inflammation in a mouse model of corneal alkali burns using cationic liposomal tacrolimus","volume":"9","author":"Lin","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123205_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/ICO.0000000000000343","article-title":"Topically administered gold nanoparticles inhibit experimental corneal neovascularization in mice","volume":"34","author":"Cho","year":"2015","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10717544.2021.2021323","article-title":"Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123205_bib40","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1039\/D3BM00893B","article-title":"Platelet-derived extracellular vesicles for drug delivery","volume":"11","author":"Yao","year":"2023","journal-title":"Biomater. Sci."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123205_bib41","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1039\/D1BM00924A","article-title":"Targeted delivery of dexamethasone in acute pneumonia","volume":"9","author":"Ma","year":"2021","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123205_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100115","article-title":"Reshaping the inflammatory environment in rheumatoid arthritis joints by targeting delivery of berberine with platelet-derived extracellular vesicles","volume":"1","author":"Ma","year":"2021","journal-title":"Adv. Nanobiomed Res."},{"key":"10.1016\/j.biomaterials.2025.123205_bib43","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.2147\/OPTH.S265701","article-title":"Human platelets and derived products in treating ocular surface diseases - a systematic review","volume":"14","author":"You","year":"2020","journal-title":"Clin. Ophthalmol."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123205_bib44","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.3390\/ijms22189701","article-title":"Characterization and therapeutic use of extracellular vesicles derived from platelets","volume":"22","author":"Spakova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123205_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.791882","article-title":"New insights into the regulatory roles of extracellular vesicles in tumor angiogenesis and their clinical implications","volume":"9","author":"Huang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biomaterials.2025.123205_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122502","article-title":"Extracellular vesicles purified from serum-converted human platelet lysates offer strong protection after cardiac ischaemia\/reperfusion injury","volume":"306","author":"Livkisa","year":"2024","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123205_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123205_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1208\/s12249-021-01977-0","article-title":"Review of approaches for increasing ophthalmic bioavailability for eye drop formulations","volume":"22","author":"Lanier","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood-brain barrier: a review","volume":"19","author":"Ramos-Zald\u00edvar","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biomaterials.2025.123205_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123205_bib51","series-title":"Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy","first-page":"27","article-title":"Extracellular vesicles and their interplay with biological membranes","author":"Pastorin","year":"2021"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123205_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/pharmaceutics13010122","article-title":"Unlocking the power of exosomes for crossing biological barriers in drug delivery","volume":"13","author":"Elliott","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123205_bib53","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123205_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1083\/jcb.201506084","article-title":"Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER","volume":"213","author":"Heusermann","year":"2016","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123205_bib55","first-page":"1","article-title":"Therapies based on nanoparticles for eye drug delivery, Ophthalmol","volume":"9","author":"Meza-Rios","year":"2020","journal-title":"Ther"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123205_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/pharmaceutics12050442","article-title":"Extracellular vesicle- and extracellular vesicle mimetics-based drug delivery systems: new perspectives, challenges, and clinical developments","volume":"12","author":"Gangadaran","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123205_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.734720","article-title":"Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities","volume":"9","author":"Claridge","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123205_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129749","article-title":"Flavonoids in microheterogeneous media, relationship between their relative location and their reactivity towards singlet oxygen","volume":"10","author":"G\u00fcnther","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2025.123205_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108960","article-title":"Kaempferol ameliorate the prognosis of Aspergillus fumigatus keratitis by reducing fungal load and inhibiting the Dectin-1 and p38 MAPK pathway","volume":"216","author":"Jia","year":"2022","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123205_bib60","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.5966\/sctm.2015-0367","article-title":"Umbilical cord-derived mesenchymal stem cell-derived exosomal micrornas suppress myofibroblast differentiation by inhibiting the transforming growth factor-\u03b2\/smad2 pathway during wound healing","volume":"5","author":"Fang","year":"2016","journal-title":"Stem Cells Transl. Med."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T05:33:30Z","timestamp":1741584810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S0142961225001243"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123205","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.25.614855","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-derived extracellular vesicle drug delivery system loaded with kaempferol for treating corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123205"}}